Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Paldeep Atwal

Clinical Genetics (M.D.) West Palm Beach, FL Medical Doctor

NPI 1518201243 CMS profile 1368039

515 N Flagler Dr Ste 350, West Palm Beach, FL 33401

Open in the dashboard

General payments

$120,982

144 records reported · program years 2019–2025

Research payments

$1,530

Paid to them · 2 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Paldeep Atwal of West Palm Beach, FL is reported in the CMS Open Payments database as having received $120,982 across 144 general payments and $1,530 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 94th percentile of Clinical Genetics (M.D.) profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $117 1
2024 General $4,816 7
2023 General $9,391 17
2022 General $22,485 18
2021 General $14,950 17
2021 Research $1,530 2
2020 General $13,920 15
2019 General $55,302 69

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Paldeep Atwal
  • Clinical Genetics (M.D.) median
  • Middle half of Clinical Genetics (M.D.)
  • National median

In program year 2025, general payments to Paldeep Atwal were reported at $117. Among 315 Clinical Genetics (M.D.) profiles paid that year, the median was $255 and the middle half received between $85 and $3,583.

Show as a table
Year Paldeep Atwal Clinical Genetics (M.D.) median Middle half National median
2019 $55,302 $130 $24–$2,691 $163
2020 $13,920 $126 $30–$3,700 $114
2021 $14,950 $185 $30–$3,777 $132
2022 $22,485 $136 $44–$2,749 $149
2023 $9,391 $196 $55–$5,220 $160
2024 $4,816 $165 $46–$3,171 $164
2025 $117 $255 $85–$3,583 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Genzyme Corporation $55,879 54 payments
  2. Horizon Therapeutics plc $33,374 47 payments
  3. PTC Therapeutics, Inc. $22,583 24 payments
  4. Ipsen Biopharmaceuticals, Inc $8,666 9 payments
  5. BioMarin Pharmaceutical Inc. $265 5 payments
  6. Sanofi-Aventis U.S. LLC $137 3 payments
  7. Sentynl Therapeutics, Inc. $45 1 payment
  8. Amicus Therapeutics, Inc. $32 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $49,348 20 payments
  2. Honoraria $28,203 15 payments
  3. Travel and Lodging $23,519 42 payments
  4. Consulting Fee $16,550 8 payments
  5. Food and Beverage $3,362 59 payments
Products named General payments · program years 2019–2025
  1. RAVICTI $22,611 27 payments
  2. FABRAZYME Genetic Disease $20,367 21 payments
  3. CEREZYME $12,274 11 payments
  4. CERDELGA $12,258 10 payments
  5. PROCYSBI $10,697 17 payments
  6. LUMIZYME $10,381 10 payments
  7. DISEASE STATE $2,781 2 payments
  8. FABRAZYME Rare Disease Genetics $2,124 2 payments
  9. ALDURAZYME $2,124 2 payments
  10. Sohonos $1,971 4 payments
  11. Other $1,827 26 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Genzyme Corporation $1,530 2 payments

Records

146 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Clinical Genetics (M.D.) in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record